Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study

Abstract Background No real‐world data exist on outcomes in patients on anticoagulants and concomitant antiarrhythmic medications. This study aims to compare the safety and effectiveness of apixaban and warfarin, first in patients with nonvalvular atrial fibrillation (NVAF) and then in patients on c...

Full description

Bibliographic Details
Main Authors: Matthew A. Wanat, Xin Wang, Rutugandha Paranjpe, Hua Chen, Michael L. Johnson, Marc L. Fleming, Susan M. Abughosh
Format: Article
Language:English
Published: Elsevier 2019-10-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
Online Access:https://doi.org/10.1002/rth2.12221